Skip to main content
Autobound logo
McKesson10-K: Restructuring charge

McKesson spends $3.375B on two major acquisitions in its Oncology & Multispecialty segment

Read at SEC EDGAR

Source

SEC EDGARMay 7, 2026

Annual report (Form 10-K)

McKesson 10-K for FY2026

Filing excerpt

On April 1, 2025, we completed the acquisition of a controlling interest in PRISM Vision for $875 million in cash...

sec.gov/Archives/edgar/data/927653/000092765326000069/mck-20260331.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Restructuring charge

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2026
Fiscal year end
03/31
Filed
May 7, 2026

More from McKesson

Company page →

More 10-K signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$3.4B (Total cash spent on acquisitions of PRISM Vision ($875M) and Core Ventures ($2.5B).)

Details

CIK
927653
Accession number
0000927653-26-000069
Timeframe
Current year
Filing year
2026
Why it matters
Vendor review likely
Signal category
Financial

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
May 12, 2026
signal_type
sec-10k
signal_subtype
restructuringCharge

Use this data

Get every 10-K signal for McKesson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at McKesson this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/27de7529-41a8-4ade-af97-865e79700728 returns this record as JSON. POST /v1/companies/enrich returns every signal for mckesson.com.

{
  "signal_id": "27de7529-41a8-4ade-af97-865e79700728",
  "signal_type": "sec-10k",
  "signal_subtype": "restructuringCharge",
  "detected_at": "2026-05-12T09:24:47.252+00:00",
  "company": {
    "name": "McKesson",
    "domain": "mckesson.com"
  },
  "data": {
    "detail": "The acquisitions of Core Ventures ($2.5B) and PRISM Vision ($875M) create urgent needs for post-merger integration of financial, operational, and clinical systems to realize synergies and manage the newly combined entities.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "Total cash spent on acquisitions of PRISM Vision ($875M) and Core Ventures ($2.5B).",
      "dollar_millions": 3375
    },
    "summary": "McKesson spends $3.375B on two major acquisitions in its Oncology & Multispecialty segment",
    "excerpts": "On April 1, 2025, we completed the acquisition of a controlling interest in PRISM Vision for $875 million in cash...",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/927653/000092765326000069/mck-20260331.htm",
    "filing_date": "2026-05-07",
    "filing_year": 2026,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Vendor review likely",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.